Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
29 Januar 2008 - 10:05PM
PR Newswire (US)
VANCOUVER, Jan. 29 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global
specialty pharmaceutical and medical device company, is scheduled
to participate in the Merrill Lynch Global Pharmaceutical,
Biotechnology and Medical Device Conference, which is being held
February 5-7 in New York, NY. Dr. William Hunter, Angiotech's
President and Chief Executive Officer, is scheduled to present on
Tuesday, February 5, at the Grand Hyatt New York, beginning at
approximately 3:20 pm ET. A Question and Answer period will
immediately follow the presentation. A live audio-only webcast will
be available to all interested parties on the company's website,
http://www.angiotech.com/ under the Investors section. About
Angiotech Angiotech Pharmaceuticals, Inc. is a global specialty
pharmaceutical and medical device company with over 1,500 dedicated
employees. Angiotech discovers, develops and markets innovative
treatment solutions for diseases or complications associated with
medical device implants, surgical interventions and acute injury.
To find out more about Angiotech
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at
http://www.angiotech.com/. CONTACT: Deirdre Neary, Manager,
Investor Relations, Angiotech Pharmaceuticals, Inc., (604)
222-7056, DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT:
Deirdre Neary, Manager, Investor Relations, Angiotech
Pharmaceuticals, Inc., (604) 222-7056,
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel